Study on a mitochondrial target and blood sugar control
Treatments studied
This study tests a medicine called XBD173 to see how it affects blood sugar by targeting a protein inside cells' mitochondria. It may help people without diabetes learn about new ways to regulate blood sugar.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You do not have diabetes.
- You are willing to use birth control (if applicable) and not pregnant or breastfeeding.
- You are not taking certain medications (like some antibiotics, antifungals, seizure meds, blood thinners, thyroid medicine, or oral contraceptives).
- Your routine blood tests are normal (kidney, liver, and blood cell levels).
- You do not have a serious medical condition affecting your blood, liver, kidneys, or hormone system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug that may help your body use insulin better and improve how your cells produce energy. It might lead to better blood sugar control and less insulin needed.
This early study looks at how a new approach may affect energy-making (mitochondria) and blood-vessel signaling in people with insulin-dependent type 1 diabetes. It may help researchers understand whether these pathways can be improved in type 1 diabetes.
This study tests a new medicine (NNC9733-0001) to see how it works in healthy people and in people with type 2 diabetes. It helps researchers understand safety and how the body processes the drug.
This study tests whether a new medication can improve heart and metabolic health (like blood pressure and blood sugar control) in Black adults with obesity and high blood pressure. It aims to reduce risk of diabetes and heart disease.
This study tests if adding a non-insulin medication can lower the amount of insulin needed while improving heart and metabolic health in people with type 1 diabetes. It may also help understand how this approach works in people with a genetic form of diabetes (GCK-MODY).
This study tests a new medicine called HMS1005 in people with type 2 diabetes. Researchers want to see how safe it is and how the body responds to different doses. You may qualify if you have type 2 diabetes that is either untreated or controlled with common diabetes medications.
Hear when a new Heathly Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.